Many patients with vitiligo have become disillusioned with healthcare due to a lack of long-term, effective management strategies. However, Dr. Chovatiya believes the impending ruxolitinib cream approval may signal real change in the treatment of the skin disorder.
The results show a mean VASI score prior to treatment of 0.55, which increased to 1.97 at the 6 month mark.
Dr. Arkin speaks to how the psychological burdens of vitiligo can be exacerbated in younger patients, and what anticipated approvals such as ruxolitinib cream could mean for pediatric populations.
Usage of subtenon and regional anesthesia decreased, while general and combined topical and intracameral anesthesia was stable.
New phase 3 data show a microencapsulated form of the topical antiseptic and vitamin D derivative is beneficial and tolerable over 12 weeks.
However, vision is no longer significantly improved after 4 years of using anti-VEGF therapies.
Non-vegetable nitrate intake was not associated with less frequent incident open-angle glaucoma.
After implantation, investigators observed very good distance, intermediate and near functional visual outcomes and a high percentage of subjects without visual disturbances.
This downward trend in LVS was suggested to be a product of decreased distribution of patients treated with intravitreal injections.
Low lifestyle scores were driven by non-adherence to the Mediterranean diet, with low vegetable and fish intake being most prominent.
The investigators labeled pre-existing glaucoma, high preoperative intraocular pressure, and combined keratoplasty with removal or exchange of an intraocular lens were definitely associated with an increased risk.
The aim is for the RNA-based medicine to dually serve as a treatment for multiple forms of transthyretin amyloidosis, and as a commercial contender to competing therapies.
Savanna Perry, PA-C, discussed the challenge of standing out over influencers and estheticians regarding clinical dermatology insight, and the unique offerings of different platforms.
New data from ECZTRA 6 show improved sleep quality, itch relief and quality of life among teenagers treating atopic dermatitis with the IL-13 inhibitor.
Investigators presented the study at the Netherlands Ophthalmological Society Annual Congress, noting a potential cause for this trend could be the heightened cautiousness of surgical teams following the 2 month intermission due to the COVID-19 pandemic.
The reported complications of high myopia included myopic maculopathy, glaucoma, retinal detachment, and macular neovascularization.
There were also significant social determinants including race and religion discordance between the healthcare provider and patient and caregiver responsibilities toward others.
At 12 months, the mean VA change from baseline was 17.6 for BRVO patients and 18.6 for CRVO patients in the Netherlands.
The mean values of stool scale form also increased in the kombucha cohort, while the control group remained unchanged.
Results from a cross-sectional survey suggest consistent patient preferences for treatment outcomes and means of administration.
Savanna Perry, PA-C, founder of The PA Platform, discusses the strategies and goals that go into building an online audience as a healthcare professional.
The eyelid maneuvers increased intraocular pressure by ≥40mm Hg in patients with primary open-angle glaucoma.
New phase 3 extension data show the topical PDE-4 inhibitor provided skin clearance to a significant rate of patients with psoriasis.
There were no negative safety signals in postnatal outcomes of exposed children in terms of growth, psychomotor development, and the risk of allergy, atopy, or infectious complications.
Patients with RVO in a nationwide cohort in Denmark had an increased risk to develop overall, ischemic and non-ischemic CVD compared to non-RVO control patients.
In honor of World Sickle Cell Day, Dr. Titi Fasipe shared a comprehensive overview of the current status of gene therapy and the techniques being used for sickle cell disease treatment.
A deep learning system provided accurate predictions of occurrence and severity of ROP ≤45 weeks’ PMA based on retinal photographs at first screening.
Dr. Cohen details the latest study from Yale, which indicated that women from lichen sclerosus had increased risk of developing depression and anxiety.
New research from the UK suggests educational tools for caregivers are in use and beneficial, but none are universally applied.
